About Us
EDDC launched its Fee-for-Service initiative, the EDDC Academic Research Organisation (EARO), in late 2020. This endeavour is part of EDDC’s larger goal of facilitating the translation of lab science into commercial assets in Singapore, by engaging local biotech, biopharma, and public-funded research groups.
EARO aims to drive the innovation and advancement of translational drug discovery in Singapore and to enable our scientific community to do so cost-effectively by providing access to EDDC’s specialised technologies, expertise, and connections.
3 Pillars of Our Mission & Philosophy
Platforms
Services
Technologies
Articles & Resources
While EARO supports projects at all stages of the drug discovery pathway, it has 3 core platforms for on-demand service.
High Throughput Screening
Screen from small focus sets to large diverse collections to rapidly identify hits for your target of interest using the only fully integrated automation platform in Singapore.
High Throughput Phenomics
Leverage the power of imaging in your drug screening assays to measure thousands of cellular features and gain valuable insights into MoA and complex disease biology.
Compound Hub
